Today's Top Performers In Health Services

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 91 points (-0.5%) at 16,894 as of Thursday, July 10, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 864 issues advancing vs. 2,123 declining with 163 unchanged.

The Health Services industry currently sits down 0.7% versus the S&P 500, which is down 0.4%. Top gainers within the industry include HCA Holdings ( HCA), up 0.9%, and Baxter International ( BAX), up 0.9%. On the negative front, top decliners within the industry include Mettler-Toledo International ( MTD), down 1.1%, St Jude Medical ( STJ), down 0.9%, Intuitive Surgical ( ISRG), down 0.9%, Agilent Technologies ( A), down 0.8% and UnitedHealth Group ( UNH), down 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Opko Health ( OPK) is one of the companies pushing the Health Services industry higher today. As of noon trading, Opko Health is up $0.20 (2.3%) to $8.90 on average volume. Thus far, 1.5 million shares of Opko Health exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $8.59-$8.99 after having opened the day at $8.64 as compared to the previous trading day's close of $8.70.

Opko Health, Inc., a biopharmaceutical and diagnostics company, is engaged in the discovery, development, and commercialization of novel and proprietary technologies. It operates in two segments, Pharmaceuticals and Diagnostics. Opko Health has a market cap of $3.5 billion and is part of the health care sector. Shares are up 3.1% year-to-date as of the close of trading on Wednesday. Currently there are 4 analysts who rate Opko Health a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Opko Health as a hold. The company's strengths can be seen in multiple areas, such as its largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and feeble growth in the company's earnings per share. Get the full Opko Health Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Centene ( CNC) is up $0.93 (1.2%) to $77.55 on average volume. Thus far, 321,939 shares of Centene exchanged hands as compared to its average daily volume of 804,400 shares. The stock has ranged in price between $76.09-$77.57 after having opened the day at $76.12 as compared to the previous trading day's close of $76.62.

Centene Corporation provides multi-line healthcare programs and services in the United States. It operates in two segments, Managed Care and Specialty Services. Centene has a market cap of $4.4 billion and is part of the health care sector. Shares are up 30.0% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts who rate Centene a buy, no analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Centene as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Centene Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Aetna ( AET) is up $0.45 (0.6%) to $81.64 on average volume. Thus far, 937,496 shares of Aetna exchanged hands as compared to its average daily volume of 2.4 million shares. The stock has ranged in price between $80.18-$81.77 after having opened the day at $80.38 as compared to the previous trading day's close of $81.19.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $29.0 billion and is part of the health care sector. Shares are up 18.4% year-to-date as of the close of trading on Wednesday. Currently there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and attractive valuation levels. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?

Jim Cramer: Does Saudi Arabia Think Oil Prices Are Too High?